Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C G Goetz

Showing results (191-200 of 269) with videos related to

Pageof 27
Sort By:
Neurology|August 1, 1989
Agonist substitution in advanced Parkinson's diseaseC G Goetz, K M Shannon, C M Tanner, et al.
Neurology|May 1, 1987
Parkinson's disease and motor fluctuations: long-acting carbidopa/levodopa (CR-4-Sinemet)C G Goetz, C M Tanner, H L Klawans, et al.
Clinical Neuropharmacology|April 6, 2001
Estrogen supplementation in the posthypoxic myoclonus rat modelK Kompoliti, C G Goetz, T Q Vu, et al.
Neurology|June 1, 1997
Treatment with fetal allograftsJ H Kordower, T B Freeman, R A Bakay, et al.
Clinical Neuropharmacology|October 28, 1998
Poor visual discrimination and visual hallucinations in Parkinson's diseaseN J Diederich, C G Goetz, R Raman, et al.
European Journal of Pharmacology|January 21, 1986
The effect of antimuscarinic agents on haloperidol induced behavioral hypersensitivityP M Carvey, L C Kao, C M Tanner, et al.
Neurology|November 30, 2000
Menstrual-related changes in motoric function in women with Parkinson's diseaseK Kompoliti, C L Comella, J A Jaglin, et al.
Advances in Neurology|January 1, 1983
Levodopa-free periods ("drug holidays") in the management of parkinsonismH L Klawans, C G Goetz, C M Tanner, et al.
Neurology|September 1, 1987
Controlled-release SinemetC G Goetz, C M Tanner, V S Carroll, et al.
Neurology|October 1, 1982
Pergolide mesylate and idiopathic Parkinson diseaseC M Tanner, C G Goetz, R H Glantz, et al.
Pageof 27

Showing results (191-200 of 269) with videos related to

Sort By:
Pageof 27
Neurology|August 1, 1989
Agonist substitution in advanced Parkinson's diseaseC G Goetz, K M Shannon, C M Tanner, et al.
Neurology|May 1, 1987
Parkinson's disease and motor fluctuations: long-acting carbidopa/levodopa (CR-4-Sinemet)C G Goetz, C M Tanner, H L Klawans, et al.
Clinical Neuropharmacology|April 6, 2001
Estrogen supplementation in the posthypoxic myoclonus rat modelK Kompoliti, C G Goetz, T Q Vu, et al.
Neurology|June 1, 1997
Treatment with fetal allograftsJ H Kordower, T B Freeman, R A Bakay, et al.
Clinical Neuropharmacology|October 28, 1998
Poor visual discrimination and visual hallucinations in Parkinson's diseaseN J Diederich, C G Goetz, R Raman, et al.
European Journal of Pharmacology|January 21, 1986
The effect of antimuscarinic agents on haloperidol induced behavioral hypersensitivityP M Carvey, L C Kao, C M Tanner, et al.
Neurology|November 30, 2000
Menstrual-related changes in motoric function in women with Parkinson's diseaseK Kompoliti, C L Comella, J A Jaglin, et al.
Advances in Neurology|January 1, 1983
Levodopa-free periods ("drug holidays") in the management of parkinsonismH L Klawans, C G Goetz, C M Tanner, et al.
Neurology|September 1, 1987
Controlled-release SinemetC G Goetz, C M Tanner, V S Carroll, et al.
Neurology|October 1, 1982
Pergolide mesylate and idiopathic Parkinson diseaseC M Tanner, C G Goetz, R H Glantz, et al.
Pageof 27